Summit Therapeutics (NASDAQ:SMMT) Showcases Promising Data at J.P. Morgan Healthcare Conference
Summit Therapeutics recently presented their latest developments at the 43rd Annual J.P. Morgan Healthcare Conference. The event featured discussions led by Bob Duggan, the Chairman & CEO, and Dr. Maky Zanganeh, the CEO & President. During the presentation, Summit Therapeutics outlined their future expectations and strategic plans surrounding the clinical and preclinical development of their […]
More Stories
North Korea Threatens Stronger Deterrence Ahead of US–South Korea Military Drills
By Victoria Friedman Pyongyang has denounced the upcoming annual joint U.S.–South Korean military drills on the peninsula, calling them provocative...
Trump Says He’ll Declare the Hormuz Strait a US Territory ‘Pretty Soon’
By Emel Akan President Donald Trump announced on Friday his intention to declare the Strait of Hormuz a U.S. territory,...
Hurricane Watch Issued for Hawaii’s Big Island as Tropical Storm Lala Forms
By Savannah Hulsey Pointer A hurricane watch has been issued for the Big Island of Hawaii as Tropical Storm Lala...
Earnings Are Up Over 50% So Far
By Louis Navellier Through last Friday, 88% of the S&P 500 companies have announced second-quarter results. According to FactSet Earnings...
Trump Orders Navy to Replace Newer Fighter Launch System With Older Steam Catapults
By Timothy Frudd President Donald Trump ordered the Navy on Aug. 13 to return to using steam catapults to launch...
Trade Court Upholds Trump’s Shutdown of $800 De Minimis Duty Exemption
By Matthew Vadum The U.S. Court of International Trade on Aug. 13 upheld the Trump administration’s authority to end the...